Plain-English translation of NCT06525688 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying bone and blood samples from postmenopausal women to find new protein and chemical markers that could help diagnose osteoporosis earlier and develop better treatments. By comparing women who have suffered osteoporotic fractures with women who have arthritis, scientists hope to understand exactly what goes wrong in bones affected by osteoporosis. This knowledge could lead to more targeted and effective therapies in the future.
Osteoporosis affects millions of women after menopause, but we still don't fully understand the underlying causes or have ideal ways to predict who will fracture. This study aims to fill that gap by identifying biological markers that could improve diagnosis and guide development of new, more effective treatments.
If you qualify for Group 1 (hip fracture), your bone sample will be collected during your fracture repair surgery. If you qualify for Group 2 (arthritis), your bone sample will be collected during your hip replacement surgery. All participants will also provide a fasting blood sample before or around the time of surgery. The researchers will analyze these samples to identify proteins and chemical markers related to bone loss.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Greece
Collaborators
National Hellenic Research Foundation
Enrollment target
~60 participants
Started
July 2024
Primary completion
October 2024
Sex
Female only
Last updated on clinicaltrials.gov in July 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Efstathios Chronopoulos
KAT General Hospital, Athens Greece